Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
417.5 GBX | +0.60% | +0.60% | +6.51% |
03-21 | Science Group hails "solid performance" despite profit drop | AN |
03-21 | Earnings Flash (SAG.L) SCIENCE GROUP Posts FY23 Revenue GBP113.3M | MT |
Summary
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Business Support Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.51% | 236M | C- | ||
+7.12% | 7.41B | A- | ||
-32.64% | 3.24B | - | ||
+6.75% | 2.66B | A- | ||
+11.38% | 1.75B | C+ | ||
-9.32% | 1.08B | - | - | |
+31.69% | 907M | - | ||
-7.64% | 714M | - | ||
-3.34% | 606M | C+ | ||
-8.30% | 539M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SAG Stock
- Ratings Science Group plc